UNSPSC 51161538: Eprozinol

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IJ21AK8IVJ, chemically known as 1-piperazinepropanol, 4-(beta-methoxyphenethyl)-alpha-phenyl- but generally known as eprozinol, which bears US NIH Compound Identifier 122553. European Medicines Agency schedules Eprozinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06589MIG.

UNSPSC 51161538 Eprozinol is a Commodity code for a specific anti-inflammatory pharmaceutical agent used in veterinary and human medical settings. State and local governments procure eprozinol primarily through health departments, public health agencies, and animal control or veterinary service divisions. The product is sourced as a finished pharmaceutical, typically through competitive bidding or standing supply agreements managed by procurement offices. Issuing bodies include state health departments, county health services, municipal animal control departments, and regional public health districts that maintain pharmaceutical inventories for disease management, injury treatment, or animal welfare programs.

The source provided contains no recent state and local solicitation records for eprozinol. Without posted opportunities in the most-recent state and local opportunities block, geographic concentration and representative recent contract activity cannot be characterized. Firms pursuing this code should monitor health department and animal services procurement channels in target states and track cooperative purchasing vehicles commonly used for pharmaceutical supply agreements, as activity may be posted through standing-offer or requirements contracts rather than individual RFQs or ITBs.